# Concord Drugs Ltd (CONCORD)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹81.06
Day Change: +2%
52W High: ₹92.52
52W Low: ₹29
Market Cap: ₹107 Cr

## Valuation
P/E: 184.09
P/B: 2.38
EPS: ₹0.44
Book Value: ₹33.99
Dividend Yield: 0%

## Returns
1Y Return: 163.95%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Concord Drugs Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Concord Drugs Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- BSE Filing: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-20T08:45:20.390Z
Price History Updated: 2026-05-20T08:45:20.943Z
Latest Price History Date: 2026-05-20
Technicals Updated: 2026-05-20T08:45:20.943Z
Quant Updated: 2026-05-20T08:45:20.943Z
Sentiment Updated: 2026-05-20T08:45:20.943Z
Financials Status: current
Financials Updated: 2026-05-18T13:30:00.909Z
Financials Last Attempt: 2026-05-18T13:30:00.909Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2015)
Revenue: ₹33.95 Cr
Operating Profit: ₹3.23 Cr (OPM 9.51%)
Net Profit: ₹0.34 Cr
Tax: ₹0.43 Cr

## Annual P&L History
Mar 2015: Rev ₹33.95Cr | PAT ₹0.34Cr | OPM 9.51%
Mar 2016: Rev ₹40.02Cr | PAT ₹0.7Cr | OPM 17.57%
Mar 2017: Rev ₹50.68Cr | PAT ₹1.75Cr | OPM 16.38%

## Balance Sheet (Mar 2015)
Total Assets: ₹44.68 Cr
Total Liabilities: ₹44.68 Cr
Borrowings: ₹17.31 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/concord
Disclaimer: For research and education only. Not investment advice.